Premium
Short‐ and long‐term influences of calcitonin gene‐related peptide on the synthesis of acetylcholinesterase in mammalian myotubes
Author(s) -
Da Costa Valter Luiz,
Lapa Antonio José,
Godinho Rosely O
Publication year - 2001
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0704069
Subject(s) - calcitonin gene related peptide , forskolin , medicine , endocrinology , acetylcholinesterase , myogenesis , chemistry , adenylyl cyclase , calcitonin , stimulation , skeletal muscle , biology , neuropeptide , biochemistry , receptor , enzyme
The present study analyses the short‐ (15 min – 2 h) and long‐term (24 – 48 h) influences of calcitonin gene‐related peptide (CGRP) on acetylcholinesterase (AChE) expression in the rat cultured skeletal muscle and the signal transduction events underlying CGRP actions. To assess the effect of CGRP on AChE synthesis, myotubes were pre‐exposed to the irreversible AChE inhibitor diisopropyl fluorophosphate (DFP) and treated with CGRP or forskolin, an adenylyl cyclase (AC) activator. Treatment of myotubes with 1 – 100 n M CGRP for 2 h increased by up to 42% the synthesis of catalytically active AChE with a parallel increase in the intracellular cyclic AMP. The stimulation of AChE synthesis induced by CGRP was mimicked by direct activation of AC with 3 – 30 μ M forskolin. In contrast, pre‐treatment of cultures with 100 n M CGRP for 20 h reduced by 37% the subsequent synthesis of AChE, resulting in a 15% decrease in total AChE activity after 48 h CGRP treatment. Moreover, 24 h treatment of myotubes with 100 n M CGRP reduced by 54% the accumulation of cyclic AMP induced by a subsequent CGRP treatment. These findings indicate that, in skeletal muscle cells, CGRP modulates the AChE expression in a time‐dependent manner, initially stimulating the enzyme synthesis through a cyclic AMP‐dependent mechanism. The decreased AChE synthesis observed after long‐term CGRP treatment suggests that CGRP signalling system is subject to desensitization or down‐regulation, that might function as an important adaptative mechanism of the muscle fibre in response to long‐term changes in neuromuscular transmission.British Journal of Pharmacology (2001) 133 , 229–236; doi: 10.1038/sj.bjp.0704069